Test and treat: a new standard for smear-positive tuberculosis

J Acquir Immune Defic Syndr. 2012 Sep 1;61(1):e6-8. doi: 10.1097/QAI.0b013e3182614bc5.

Abstract

Optimizing sputum smear microscopy, the principal method of tuberculosis (TB) diagnosis in high-burden settings around the world, is a critical priority for global TB control. To improve rates of testing, completion, and reporting, the World Health Organization (WHO) recently endorsed a policy of same-day diagnosis of TB by microscopy. Unfortunately, the implementation of this policy has emphasized same-day sputum collection alone, with patients required to return on a subsequent day to collect results. We use a simple decision analysis to demonstrate that the timing of results reporting has a greater impact on treatment initiation for smear-positive TB cases than the timing of specimen collection. Same-day diagnosis of smear-positive TB, including sputum collection and reporting of smear results, should be the new global standard.

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Antitubercular Agents / administration & dosage*
  • Humans
  • Mycobacterium tuberculosis / isolation & purification*
  • Sputum / microbiology*
  • Time Factors
  • Tuberculosis / diagnosis*
  • Tuberculosis / drug therapy*

Substances

  • Antitubercular Agents